Guerbet GBT.PA · EUR

Its shares trade on Euronext Paris under the ticker GBT.PA. It has been listed since 15 January 1986. In the fiscal year to 31 December 2025, it reported revenue of €786.4m and a net loss of €108.3m. At that date it held total assets of €930.0m and shareholders' equity of €267.0m.

Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company is headquartered in Villepinte, Ile-De-France. The company produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The firm operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Hugues LecatIndependent Chairman of the Board€30,334
• Mr. Jerome EstampesInterim Chief Executive officer, Chief Financial Officer, SVP - Administration, Finance, and IT, Business Development and Licensing, Member of the Executive Committee
• Mr. Philippe BourrinetDeputy Chief Executive Officer, Senior Vice President - Development, Medical & Regulatory Affairs, Chief Pharmacist, Member of the Executive Committee€11,500
• Ms. Valerie BrissartSenior Vice President - Diagnostic Imaging, Marketing Director, Member of the Executive Committee, since 2024
• Ms. Eva OhlssonSenior Vice President - Human Resources, Corporate Social Responsibility, Member of the Executive Committee
• Ms. Christine AllardSenior Vice President - Public Affairs and Communications, Member of the Executive Committee
• Ms. Charlotte BamiereSenior Vice President - Legal Affairs and Compliance, Member of the Executive Committee
• Mr. Raoul BernhardtSenior Vice President - Industrial Operations, CSR & HSE, and Procurement, Member of the Executive Committee
• Mr. Francois NicolasSenior Vice President - Research, Development, Innovation and AI, Chief Digital Officer, Member of the Executive Committee, since 2024
• Ms. Carine DagommerDirector€26,967
• Ms. Marie de La SimoneDirector, Representative of Employees
• Mr. Eric GuerbetDirector€30,767

Overall

70

Environment

70

Social

99

Governance

40

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.